Abstract
Purpose
The diagnosis of irritable bowel syndrome is symptom based, and colonoscopy is the most direct way to rule out organic colonic diseases. It is controversial on the necessity of colonoscopy for patients with suspected irritable bowel syndrome and lacking alarm features. This study was designed to verify the organic lesions and discuss the value of colonoscopy in this type of patients.
Methods
Colonoscopy of 3,332 patients with suspected irritable bowel syndrome and lacking warning signs from 2000 to 2009 were reviewed. One thousand five hundred eighty-eight patients under 50 years of age who underwent colonoscopy screening for health care in the same period were used as controls. The prevalence of different colonic organic lesions was compared between two groups.
Results
Organic colonic lesions were found in 30.3% of the patients with suspected irritable bowel syndrome (1,010/3,332) and 39.0% of the controls (619/1,588). Compared with controls, patients with suspected irritable bowel syndrome had higher prevalence of noninflammatory bowel disease and noninfectious colitis and terminal ileitis, however, had lower prevalence of diverticular disease, adenomatous polyps, and non-adenomatous polyps (all P < 0.001).
Conclusions
The diagnostic sensitivity of symptom criteria on irritable bowel syndrome without colonoscopy is not more than 69.7% in patients with suspected irritable bowel syndrome lacking warning signs. Though the method of colonoscopy is hard to screen tumor in this type of patients, it is beneficial to uncover some other relevant organic lesions such as terminal ileitis. Colonoscopy should not be refused to suspected irritable bowel syndrome patients without warning signs.
Similar content being viewed by others
References
Drossman DA, Camilleri M, Mayer EA et al (2002) AGA technical review on irritable bowel syndrome. Gastroenterology 123:2108–2131
Spiller R, Aziz Q, Creed F et al (2007) Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 56:1770–1798
Chang FY, Lu CL (2007) Irritable bowel syndrome in the 21st century: perspectives from Asia or South-east Asia. J Gastroenterol Hepatol 22:4–12
Xiong LS, Chen MH, Chen HX et al (2004) A population-based epidemiologic study of irritable bowel syndrome in Guangdong province. Zhonghua Yi Xue Za Zhi 84:278–281
Longstreth GF, Thompson WG, Chey WD et al (2006) Functional bowel disorders. Gastroenterology 130:1480–1491
Whitehead WE, Palsson OS, Feld AD et al (2006) Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome. Aliment Pharmacol Ther 24:137–146
Bellentani S, Baldoni P, Petrella S et al (1990) A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. The Local IBS Study Group. Fam Pract 7:307–312
Suleiman S, Sonnenberg A (2001) Cost-effectiveness of endoscopy in irritable bowel syndrome. Arch Intern Med 161:369–375
Hatlebakk JG, Hatlebakk MV (2004) Diagnostic approach to suspected irritable bowel syndrome. Best Pract Res Clin Gastroenterol 18:735–746
Gunnarsson J, Simren M (2008) Efficient diagnosis of suspected functional bowel disorders. Nat Clin Pract Gastroenterol Hepatol 5:498–507
Vanner SJ, Depew WT, Paterson WG et al (1999) Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol 94:2912–2917
Cash BD, Schoenfeld P, Chey WD (2002) The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 97:2812–2819
Spiegel BM, Gralnek IM, Bolus R et al (2005) Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome? Gastrointest Endosc 62:892–899
Akhtar AJ, Shaheen MA, Zha J (2006) Organic colonic lesions in patients with irritable bowel syndrome (IBS). Med Sci Monit 12:R363–R367
Silverberg MS, Satsangi J, Ahmad T et al (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19(Suppl A):5–36
Longstreth GF, Drossman DA (2002) New developments in the diagnosis and treatment of irritable bowel syndrome. Curr Gastroenterol Rep 4:427–434
Hamm LR, Sorrells SC, Harding JP et al (1999) Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria. Am J Gastroenterol 94:1279–1282
Tangri V, Chande N (2009) Microscopic colitis: an update. J Clin Gastroenterol 43:293–296
Limsui D, Pardi DS, Camilleri M et al (2007) Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 13:175–181
Chadwick VS, Chen W, Shu D et al (2002) Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 122:1778–1783
Tuncer C, Cindoruk M, Dursun A et al (2003) Prevalence of microscopic colitis in patients with symptoms suggesting irritable bowel syndrome. Acta Gastroenterol Belg 66:133–136
Spiegel BM, DeRosa VP, Gralnek IM et al (2004) Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology 126:1721–1732
Jung HK, Choung RS, Locke GR et al (2010) Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol 105:652–661
Nielsen OH, Vainer B, Rask-Madsen J (2008) Non-IBD and noninfectious colitis. Nat Clin Pract Gastroenterol Hepatol 5:28–39
Weston AP, Biddle WL, Bhatia PS et al (1993) Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 38:1590–1595
Wang SH, Dong L, Luo JY et al (2007) Decreased expression of serotonin in the jejunum and increased numbers of mast cells in the terminal ileum in patients with irritable bowel syndrome. World J Gastroenterol 13:6041–6047
Acknowledgments
We would like to thank Mr. Xiwen Wang and Mr. Liangcang Xiu for their support on statistic analysis. We also acknowledge the assistance of Dr. Jian Xu in preparing the manuscript.
Statements
The study has been approved by the ethics committee of Southern Medical University and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.
The authors of this study declare that they do not have any financial interests or affiliations with institutions, organizations, or companies.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gu, HX., Zhang, YL., Zhi, FC. et al. Organic colonic lesions in 3,332 patients with suspected irritable bowel syndrome and lacking warning signs, a retrospective case–control study. Int J Colorectal Dis 26, 935–940 (2011). https://doi.org/10.1007/s00384-011-1163-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-011-1163-2